Department of Dermatology - Open Access Policy Deposits

eScholarship stats: History by Item for May through August, 2026

Item	Title	Total requests	2026-08	2026-07	2026-06	2026-05
3nk5r7mw	Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies	604	33	20	34	517
3455571b	Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation	570	214	87	128	141
0zf2s1cf	Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia	547	137	96	142	172
02k9z6qd	Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations	453	109	82	130	132
5c88q182	Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition	402	197	37	104	64
44q8g6b8	Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).	392	222	39	51	80
1rd5q5tz	Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis	382	98	94	97	93
08j6337f	Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris	337	73	46	141	77
2dn263n7	Skin neurogenic inflammation	328	119	47	72	90
8z66m3xd	Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial	316	126	34	78	78
6hz8s1mh	Eccrine chromhidrosis secondary to hyperbilirubinemia	307	126	51	48	82
5r79d67k	Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature	282	46	43	66	127
5kk7h8hg	Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study	259	88	43	67	61
69s5d7c2	Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes	258	84	62	50	62
25j8m068	Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne	249	84	27	60	78
5fs883zh	Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies	245	122	27	39	57
0793n5z2	Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature	244	40	39	68	97
2vz565gs	Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus	238	44	40	68	86
47q8p2w7	Nevoid melanoma and eruptive nevi from erlotinib	235	34	33	64	104
76r5t591	Guidelines of care for the management of atopic dermatitis Section 3. Management and treatment with phototherapy and systemic agents	234	102	43	40	49
1rw3692c	Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis	232	84	28	64	56
216788xg	Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study	232	53	17	86	76
49f6450d	Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris	230	64	38	56	72
5xs3g48j	Acne and Rosacea	230	51	35	42	102
0vp716bx	Pediatric chronic hand eczema: Epidemiology, clinical presentation, and management	229	74	46	49	60
62d7n4g9	Designing a broad-spectrum integrative approach for cancer prevention and treatment	229	66	25	36	102
1h87c6v1	S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis	228	88	38	48	54
3m85j4j2	DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth	226	52	53	66	55
4mj865qb	Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel	226	112	36	43	35
0g0537ph	Beneficial Effects of Early Pulsed Dye Laser Therapy in Individuals with Infantile Hemangiomas	224	135	16	29	44
2qr3w771	Urgent safety considerations for dermatologic surgeons in the COVID-19 pandemic	223	59	23	43	98
47p4d8zv	Penicillamine-associated cutis laxa and milia en plaque - case report and review of cutaneous changes associated with penicillamine	221	47	15	54	105
6t87g6qr	The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens	219	37	39	53	90
2800q59v	TREM2 macrophages induced by human lipids drive inflammation in acne lesions	215	40	39	60	76
8p66q9fv	Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum	215	41	39	45	90
5sp112v7	Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus	214	80	49	44	41
9t16k3hw	Evaluation of stenoses using AI video models applied to coronary angiography	211	51	28	63	69
1xf7w7x4	Characteristics of research tracks in dermatology residency programs: a national survey	206	31	36	65	74
25q9w6r9	Dupilumab for bullous pemphigoid with intractable pruritus	196	24	35	50	87
85m1b2b9	The microbiome in patients with atopic dermatitis	196	32	29	83	52
05j80943	Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies	194	56	29	58	51
0sg0z14s	Genitogluteal porokeratosis in an HIV-positive man: a case report and review of the literature on genital porokeratosis	194	39	28	39	88
68c7v95d	Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	194	75	33	46	40
22t2148g	Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations	193	41	19	49	84
55q795hc	Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis	193	45	24	64	60
7bx0q1dh	Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors	192	27	24	84	57
3c12d713	The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis	191	73	31	55	32
67t6b870	Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel	190	69	47	23	51
4pn6h3g6	The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis	189	79	27	42	41
7gn5j3gp	Incomplete human reference genomes can drive false sex biases and expose patient-identifying information in metagenomic data	189	80	24	37	48

Top

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.